Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 3526 - 3550 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Gangliosides LMSP0601DG05
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • KDN-GM2(d18:1/24:0)
 44262608 1426.891188 C71H130N2O26
LMSL03001282
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-tetratriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/34:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
 126457723 1292.949827 C71H136O17S
Diacylglycerophosphoinositolglycans LMGP15010203
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(17:0/16:2(9Z,12Z))
 126457571 1630.774308 C72H127O38P
Diacylglycerophosphoinositolglycans LMGP15010236
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:2(9Z,12Z)/14:0)
 126457604 1630.774308 C72H127O38P
Gangliosides LMSP0601AK03
  • GD3(d18:1/20:0)
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44262046 1499.871182 C72H129N3O29
Diacylglycerophosphoinositolglycans LMGP15010202
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(17:0/16:1(9Z))
 126457570 1632.789958 C72H129O38P
Diacylglycerophosphoinositolglycans LMGP15010230
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:1(9Z)/14:0)
 126457598 1632.789958 C72H129O38P
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AI01
  • Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Leb(d18:1/16:0)
 44260676 1518.865763 C72H130N2O31
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AG01
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Ley-6(d18:1/16:0)
 44261020 1518.865763 C72H130N2O31
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type IV H(d18:1/16:0)
 44260228 1534.860678 C72H130N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM01
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260468 1534.860678 C72H130N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260564 1534.860678 C72H130N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type I B antigen(d18:1/16:0)
 44260644 1534.860678 C72H130N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type II B antigen(d18:1/16:0)
 44261004 1534.860678 C72H130N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV01
  • Gala 1-3Lex(d18:1/16:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261548 1534.860678 C72H130N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AW01
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261612 1534.860678 C72H130N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BB01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261636 1534.860678 C72H130N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ01
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260292 1550.855593 C72H130N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF01
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44260412 1550.855593 C72H130N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA01
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261628 1550.855593 C72H130N2O33
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN08
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44260595 1405.917342 C72H131N3O23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC03
  • Forssman antigen(d18:1/20:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44260182 1485.891917 C72H131N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD03
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Para-Forssman x3b(d18:1/20:0)
 44260190 1485.891917 C72H131N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC03
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44260390 1485.891917 C72H131N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD03
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44260398 1485.891917 C72H131N3O28
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024